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INTRODUCTION
Between one and five percent of travelers from
industrialized countries to the developing world seek
medical attention during or immediately after their
travel.1 International travelers who present to the
emergency department (ED) with fever pose a unique
challenge to the emergency physician (EP). In addition
to the usual causes of fever, the EP must consider less
common diseases in the differential diagnosis. We
present a case of typhoid fever, one of the most
common causes of fever in the international traveler.2
CASE
A 16-year-old male presented to a pediatric ED two
weeks after returning from Bangladesh with two days
of headache, dysuria, diaphoresis, chills, and fever to
40 degrees Celsius. He had been seen at an urgent
care center the day before presentation and was
treated with ibuprofen. He was sent to the ED because
his blood cultures had grown gram negative rods. He
had spent six weeks in undeveloped areas of
Bangladesh consuming local food and water and
reported no symptoms while traveling. None of his
family members were ill. A review of systems was
otherwise negative. He had no previous medical
problems, surgeries, or allergies. He had been taking
ibuprofen and acetaminophen for his symptoms. He
was born in Bangladesh and his immunizations were
up to date.
Vital signs demonstrated a temperature of 39.2
degrees Celsius, heart rate of 100 beats per minute,
respiratory rate of 16 breaths per minute, blood
pressure of 133/61 mmHg. His physical examination
was normal except for a mildly ill appearance and
mild diaphoresis.
His complete blood count demonstrated a white blood
cell count of 6.3 x 109/L with 52 percent neutrophils
and 32 percent bands. His electrolyte panel,
hemoglobin, hematocrit, and platelet counts were
normal. Liver function tests were abnormal with an
AST of 98 IU/L and an ALT of 82 IU/L. The protein,
albumin, bilirubin, and alkaline phosphatase were
normal. C-reactive protein was elevated at 6.7 mg/dl
and the erythrocyte sedimentation rate was elevated
at 22 mm/hour. Fecal leukocytes were not present. A
malaria smear sent from the urgent care center was
normal.
The patient was administered 2 grams of ceftriaxone
intravenously. While ambulating, the patient became
pre-syncopal and was given 2 liters of intravenous
normal saline. He was admitted to the pediatric ward
for gram negative bacteremia. After several days, urine
and fecal cultures showed no growth, but both blood
cultures grew Salmonella typhi.
DISCUSSION
Typhoid fever is caused by ingesting food or water
contaminated with feces or urine containing the
bacterium Salmonella typhi. While common in the
United States and Europe in the 19th century,
improvements in water and sewage systems have
relegated this disease to the developing world. Over
70 percent of cases of typhoid fever in the United
States are associated with travel.1 Risk factors for
contracting the disease while in an endemic region
include ingesting local food, water, or unpasteurized
milk products, having close contact with a person who
has recently had typhoid fever, and staying in facilities
that do not permit adequate personal hygiene.3 The
incidence has been reported at 1 in 10,000 to 1 in
100,000 in travelers to endemic regions, most
commonly the Indian subcontinent, the Philippines,
Mexico, and South America.1,2
Typhoid fever is acquired when the ingested bacteria
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to the small intestine, where they invade the mucosa
and spread to the liver, spleen, and mesenteric lymph
nodes. The gastric acid represents a significant barrier
to infection; therefore patients with decreased acidity,
such as those on H-2 blockers, proton pump
inhibitors, or antacids, the elderly, or patients with
previous gastrectomy, are at increased risk. The
incubation period for typhoid fever is usually 7 to 14
days but may be as long as eight weeks.2,3 Most
patients who present with typhoid fever are ages 5 to
25. Children less than 5 years old may have a
nonspecific illness that is rarely recognized to be
typhoid fever.3
After the 7 to 14 day incubation period, bacteremia
develops and the patient experiences fever, chills,
malaise, anorexia, nausea, generalized abdominal pain,
nonproductive cough, myalgias, and a dull frontal
headache. Constipation is common in adults and
diarrhea is common in children and HIV patients.
Intermittent confusion or an apathetic affect is
sometimes present, and seizures may occur in children
less than 5 years old. Fever is low grade initially but
can reach 40 degrees Celsius. Relative bradycardia
is sometimes present but is not consistently found.
Physical examination will commonly demonstrate a
coated tongue, abdominal tenderness, and
hepatosplenomegaly. Rose spots, which are blanching
erythematous maculopapular lesions 2 to 4 mm in
diameter, are reported in 5 to 30 percent of cases
and usually occur on the abdomen and chest. They
are easily overlooked in dark skinned patients.3
Laboratory evaluation usually reveals a normal or low
hematocrit, platelet count, and white blood cell count.
Disseminated intravascular coagulation may be
suggested by laboratory tests but is rarely of clinical
significance. Liver transaminases are usually two to
three times the upper limit of normal.3
Complications occur in 10 to 15 percent of patients
and are more likely to develop in patients who have
been ill for more than two weeks. Serious
complications include gastrointestinal bleeding,
intestinal perforation, and typhoid encephalopathy.
Gastrointestinal bleeding is caused by erosion of a
necrotic Peyer’s patch into an enteric vessel. Usually
the bleeding is minor, but in 2 percent of cases it can
be massive and fatal if not aggressively treated.
Intestinal perforation occurs in 1 to 3 percent of
patients. Presentations of encephalopathy range from
agitation to obtundity, with severe coma being
infrequent. Other complications noted include
hepatitis, myocarditis, meningitis, bronchitis,
pneumonia, focal abscess, pharyngitis, and
miscarriage.3
A relapse can occur in 10 to 15 percent of patients
two to three weeks after their initial fever resolves.
The bacterium isolated will usually have the same
antibiotic resistance pattern as the initial infection.3 The
overall fatality rate is less than one percent, but varies
significantly from country to country.3
The diagnosis of typhoid can be difficult due to the
nonspecific nature of the symptoms. Blood cultures
are the test of choice and are positive in 60 to 80
percent of patients. Stool cultures are positive in 30
percent of patients. Bone marrow culture is the most
sensitive test, and serologic tests are available, but
both have little utility in the ED.3
Treatment of typhoid fever centers on the
administration of effective antibiotics. Much of the data
on the treatment of typhoid fever are from areas where
it is endemic. There is little data on treatment in non-
endemic areas and on returning travelers. Resistance
patterns among S. typhi in the area traveled may help
guide therapy as there are regional reports of resistance
to fluoroquinolones and cephalosporins. Despite these
reports, fluoroquinolones remain the antibiotics of
choice in children as well as adults due to a cure rate
exceeding 96 percent and a less than 2 percent
carriage or relapse. The typical course of therapy is
five to seven days. Other effective antibiotics include
third-generation cephalosporins and azithromycin.
Aztreonam and imipenem are considered third-line
antibiotics. Chloramphenicol, amoxicillin, and
trimethoprim-sulfamethoxazole are appropriate
choices in areas of the world where fluoroquinolones
are not available or affordable. In most areas of the
world where typhoid is endemic, treatment is
administered as an outpatient with oral antibiotics and
bed rest.3Page 78 The California Journal of Emergency Medicine VI:4, Oct-Dec, 2005
The treatment of choice in severe typhoid is a parenteral
fluoroquinolone for a minimum of 10 days.
Dexamethasone at an initial dose of 3 mg/kg given
intravenously over 30 minutes followed by 1 mg/kg
every 6 hours for eight additional doses lowered
mortality from 50 percent to 10 percent in Indonesian
adults and children.4,5 Hydrocortisone at a lower dose
was not effective.6 Any patients in whom
gastrointestinal perforation or hemorrhage is suspected
will require fluid resuscitation, broad spectrum
antibiotics, and surgical consultation.3
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